We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Special Mask Aids Eye Surgery Recovery

By HospiMedica staff writers
Posted on 30 May 2007
A specially designed eye mask intended for use after cosmetic eyelid surgery (blepharoplasty) assists patient recovery. More...


The eye surgery recovery mask is made of a soft and comfortable breathable fabric that has a pocket on each side that holds a crescent-shaped ActiPatch to assure proper placement of therapy over each eye. The mask is designed to allow patients to continue their normal activities during daytime treatment; at night, the patient can then move the mask over the eyes to receive treatment on both the upper and lower lids while sleeping.

The ActiPatch is a drug-free anti-inflammatory patch with an embedded battery-operated microchip that delivers weeks of continuous pulsed therapy. This causes recharging of the cell membrane, driving out edematous fluid along with by-products of the damaged tissue. This in turn causes a reduction in the edema and inflammation associated with tissue injury. The patented ActiPatch delivery system has been clinically proven to reduce swelling and bruising by up to 50%, concomitantly reducing the need for pain medication. Both the eye surgery recovery mask and the Actipatch device are products of BioElectronics Corp. (Frederick, MD, USA).

"We believe that providing a simple way to place the therapy in the desired area without the use of adhesive will simplify post-surgical care for both the patient and the recovery staff,” said Ms. Lauren Jarman, the designer of the mask.

Cosmetic eyelid surgery is usually performed to counteract the apparent effects of aging upon eyelid tissues (bags and bulges). Wrinkles can also be reduced through blepharoplasty. These goals are accomplished by removing excess skin, fats, and muscle.


Related Links:
BioElectronics

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.